Research
Helping shape the future of eye care through research and collaboration
Sutherland Eye Surgeons is committed to delivering the highest standard of patient care, and we actively participate in advancing ophthalmic medicine through innovative treatments and clinical research.
If you have any patients who may be suitable for, or interested in participating in a clinical trial, we will welcome the opportunity to discuss their potential involvement.
Please contact us even if you are unsure as we are happy to review potential candidates. Full eligibility is determined by the study protocol.
For questions or possible referrals:
Catherine - Study Coordinator
Phone: 02 9521 8402
Email: [email protected]
ADARx
- Phase II
- randomised
- masked
- placebo-controlled
Geographic atrophy secondary to AMD
WHO TO REFER
Patients aged 60+ with geographic atrophy secondary to AMD.
TREATMENT
ADX-038 — an investigational siRNA therapy targeting complement factor B, given by subcutaneous injection.
GAMBIT
- Phase IIA
- randomised
- sham-controlled
Bilateral geographic atrophy
WHO TO REFER
Patients with bilateral geographic atrophy secondary to AMD.
TREATMENT
OLX10212 — an investigational RNA- interference therapy, given by intravitreal injection.
ARROWHEAD
- First-in-human
- dose-escalation study
Geographic atrophy secondary to AMD
WHO TO REFER
Patients with geographic atrophy secondary to AMD who may be suitable for a first-in- human study.
TREATMENT
ARO-033 — an investigational RNA- interference therapy, given by subcutaneous injection.
SAR-EFC18627
- Phase III
- randomised
- double-masked
Neovascular (wet) AMD
WHO TO REFER
Patients with neovascular AMD who may be suitable for a gene-therapy trial.
TREATMENT
SAR402663 — a one-time intravitreal gene therapy designed to provide sustained VEGF inhibition.
For all appointments and enquiries, please phone 02 9521 8402
Monday
Tuesday
Wednesday
Thursday
Friday
8:30am – 5:00pm
8:30am – 5:00pm
8:30am – 5:00pm
8:30am – 5:00pm
8:30am – 5:00pm
Suite 5, Level 1
570 President Ave
Sutherland NSW 2232
Website by: 